AORTArtivion Inc. Common Stock
28.08USD-2.57%Mkt Cap: 1.37B $P/E:

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; Carbon…

Key Statistics

Company
Market Cap1.37B $
Enterprise Value1.69B $
Revenue (TTM)471.47M $
Gross Profit284.23M $
Net Income (TTM)9.77M $
Revenue/Share9.852 USD
Last Price28.08 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.8K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)35.80
PEG643.75
EV/EBITDA26.60
EV/Revenue3.59
P/S2.89
P/B3.06
EPS (TTM)-0.06
EPS (Forward)0.78
52W Range
19.1631% of range48.25
52W High48.25 USD
52W Low19.16 USD
Profitability
Gross Margin64.40%
Oper. Margin9.01%
EBITDA Margin13.51%
Profit Margin2.21%
ROE2.18%
ROA1.10%
Growth
Revenue Growth11.30%
Earnings Growth
Cash Flow & Leverage
Operating CF39.88M $
CapEx (TTM)39.04M $
FCF Margin2.78%
FCF Yield0.96%
Net Debt330.65M $
Net Debt/EBITDA5.19
Balance Sheet
Debt/Equity0.57
Current Ratio3.47
Quick Ratio1.76
Book Value/Sh9.151 USD
Cash/Share1.586 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateDec 9, 2015
Pay Date
Splits
Last Split3:2
Split DateDec 28, 2000
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)42.15 USD
Upside (mean)+50.1%
Target Range38.00 USD48.00 USD
$38.00+50.1% to mean$48.00
# Analysts8
Ownership
Shares Out.48.76M
Float46.19M
Insiders4.47%
Institutions96.00%
Short Interest
Short Ratio4.7d
Short % Float6.67%
Short % Out.5.55%
Shares Short2.71M
Short (prev mo.)2.18M
Technical
SMA 5024.82 (+13.2%)
SMA 20034.79 (-19.3%)
Beta1.25
S&P 52W Chg18.16%
Avg Vol (30d)527.31K
Avg Vol (10d)790.72K
Technical Indicators
RSI (14)57.7
MACD1.0758
MACD Signal1.0487
MACD Hist.+0.0270
BB Upper29.72 USD
BB Middle27.24 USD
BB Lower24.77 USD
BB Width18.14%
ATR (14)1.259 USD
Vol Ratio (20d)0.66x